Showing 1 - 11 results of 11 for search 'Mustapha Tehfe', query time: 3.07s
Refine Results
-
1
-
2
-
3
-
4
-
5
Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC by Camille Gauvin, Vimal Krishnan, Imane Kaci, Danh Tran-Thanh, Karine Bédard, Roula Albadine, Charles Leduc, Louis Gaboury, Normand Blais, Mustapha Tehfe, Bertrand Routy, Marie Florescu
Published 2021-01-01
Article -
6
The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy by Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, Wiam Belkaid, Danh Tran-Thanh, Julie Malo, Marion Tonneau, Omar El Ouarzadi, Marie Florescu, Mustapha Tehfe, Normand Blais
Published 2023-01-01
Article -
7
Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience by Rami Nassabein, Laura Mansour, Corentin Richard, Franck Vandenbroucke-Menu, Francine Aubin, Jean-Pierre Ayoub, Michel Dagenais, Real Lapointe, Richard Letourneau, Marylène Plasse, André Roy, Simon Turcotte, Mustapha Tehfe
Published 2021-05-01
Article -
8
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy by Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Archana Srivastava, Anna Schab, Thierry Alcindor, Adrian Langleben, Lucas Sideris, Mahmoud Abdelsalam, Mustapha Tehfe, Felix Couture, Gerald Batist, Petr Kavan
Published 2023-12-01
Article -
9
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma by Houda Bahig, Francine Aubin, John Stagg, Olguta Gologan, Olivier Ballivy, Eric Bissada, Felix-Phuc Nguyen-Tan, Denis Soulières, Louis Guertin, Edith Filion, Apostolos Christopoulos, Louise Lambert, Mustapha Tehfe, Tareck Ayad, Danielle Charpentier, Rahima Jamal, Philip Wong
Published 2019-01-01
Article -
10
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma by Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox, James T. Topham, Petr Kavan, Derek Jonker, Stephen Welch, Felix Couture, Frederic Lemay, Mustapha Tehfe, Mohammed Harb, Nathalie Aucoin, Yoo-Joung Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, Christina A. Kim, Pan Du, Shidong Jia, David F. Schaeffer, Sharlene Gill, Dongsheng Tu, Chris J O’Callaghan
Published 2022-08-01
Article -
11
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019 by Joanna Gotfrit, Rachel Goodwin, Timothy Asmis, Angela J. Hyde, Thierry Alcindor, Francine Aubin, Scott Berry, Dominick Bossé, Colin Brown, Ronald Burkes, Margot Burnell, Bruce Colwell, Jessica Corbett, Jeff Craswell, Nathalie Daaboul, Mark Doherty, D. A. Barry Fleming, Luisa Galvis, Rakesh Goel, Mohammed Harb, Alwin Jeyakumar, Derek Jonker, Erin Kennedy, Michael Lock, Aamer Mahmud, Patrick H. McCrea, Vimoj Nair, Rami Nassabein, Carolyn Nessim, Ravi Ramjeesingh, Muhammad Raza, Wissam Saliba, Satareh Samimi, Simron Singh, Stephanie Snow, Mustapha Tehfé, Michael Thirlwell, Mario Valdes, Stephen Welch, Michael Vickers
Published 2021-05-01
Article